Skip to main content
. 2021 Dec 20;14(4):e14608. doi: 10.15252/emmm.202114608

Figure 4. Individualized therapeutic options in 56 pediatric high‐risk cancers.

Figure 4

  • A
    Overview of each patient’s precision oncology platform results. The highest tier of therapy options for each patient is shown. A total of 55 recommendations were made in 39 patients.
  • B
    Tier of therapy and related molecular alterations. Structural variant (SV), single‐nucleotide variant (SNV) with loss of heterozygosity (LOH) in a tumor suppressor gene, copy number variant (CNV).
  • C, D
    Treatment response by therapy tier. Fourteen of 29 patients with molecular‐based therapeutic options received the treatment.
  • E
    Tests contributing to the identification of treatment by tier.